Meeting
2023 ASCO Genitourinary Cancers Symposium
Partial gland ablation outcomes for localized prostate cancer in patients with MRI-visible and MRI-invisible lesions.
Authors
Alec Zhu
Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY
Alec Zhu , Sofia Gereta , Judith Stangl-Kremser , Daniel Margolis , Leonardo Daniel Borregales , Spyridon P. Basourakos , Timothy D McClure , Jim C. Hu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 368)
DOI
10.1200/JCO.2023.41.6_suppl.368
Abstract #
368
Poster Bd #
N6
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Defining the index lesion for salvage partial gland ablation after radiation therapy for localized prostate cancer.
First Author: Arjun Sivaraman
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of multiparametric magnetic resonance imaging findings with oncologic outcomes in non-palpable localized prostate cancer.
First Author: Abhishek Kumar
Poster
2024 ASCO Genitourinary Cancers Symposium
Microboost dose escalation for localized prostate cancer within a statewide radiation oncology quality consortium.
First Author: Samuel Regan
Poster
2023 ASCO Genitourinary Cancers Symposium
Cardiovascular and thromboembolic events associated with intense neoadjuvant androgen deprivation therapy followed by prostatectomy in patients with localized prostate cancer: A meta-analysis of clinical trials.
First Author: Eduardo Felicio Campos